Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients
ConditionCritical Ill Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorAssiut University
About this trial
The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.
Eligibility criteria
Qualifiers
patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis
diabtic Patients 3-animic Patients
Disqualifiers
Patients under 18 years of age
ICU stay < 24 h
patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .
Trial design
Treatments tested in this trial
- Hbg and RDW
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov